(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2021 | |
---|---|---|---|
Operating cash flow (direct method) | |||
Cash income from operating activities | |||
Cash paid | -944.3K | ||
Payments to suppliers for goods and services | ---944.3K | ---- | ---- |
Direct interest received | --14.42K | ---- | ---- |
Operating cash flow | ---929.88K | ---- | ---- |
Investing cash flow | |||
Cash flow from continuing investing activities | 142.02K | ||
Net PPE purchase and sale | ---2.18K | ---- | ---- |
Net business purchase and sale | --144.19K | ---- | ---- |
Cash from discontinued investing activities | |||
Investing cash flow | --142.02K | ---- | ---- |
Financing cash flow | |||
Cash flow from continuing financing activities | 9.54M | 2 | |
Net issuance payments of debt | --159.11K | ---- | ---- |
Net common stock issuance | --9.38M | ---- | --2 |
Cash from discontinued financing activities | |||
Financing cash flow | --9.54M | ---- | --2 |
Net cash flow | |||
Beginning cash position | 0.00%2 | --2 | ---- |
Current changes in cash | --8.75M | ---- | --2 |
End cash Position | 437,729,300.00%8.75M | --2 | --2 |
Free cash from | ---932.05K | ---- | ---- |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
No Data